SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101 (API ...
A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.
Seongnam, South Korea Saturday, December 27, 2025, 17:00 Hrs [IST] ...
Karnataka has urged the Centre to establish a National Institute of Pharmaceutical Education and Research (NIPER) in the state, citing its strong pharmaceutical and biotechnology ecosystem, skilled ...
This year, 84 companies were newly listed on the KOSDAQ market, while 38 companies were delisted. According to the KOSDAQ ...
The Chosun Ilbo on MSN
Dong-A Socio Group targets global market with CDMO, ADC platforms
Dong-A Socio Group is targeting the global market with a diversified strategy encompassing new drug development, raw pharmaceutical CDMO (contract development and manufacturing organization), ...
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
The HPAPI market is expanding rapidly, driven by oncology, targeted therapies, and precision medicine, with a projected value of over $60 billion by 2034. Technological advancements in synthetic ...
Karthik Ramgopal and Daniel Hewlett discuss the evolution of AI at LinkedIn, from simple prompt chains to a sophisticated ...
Learn how to overcome Magento’s common SEO challenges and build a fast, structured, and AI-ready ecommerce store.
Its open-source software could be the answer to building an AI ecosystem. Meta rebuilt its AI organization to prioritize ...
The Legion Pro 5 earns its stripes with an excellent OLED screen and a punchy keyboard, making it a compelling midrange gaming rig. Its CPU grunt and battery life don’t inspire, but its gaming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback